Stanford Graduate School of Business (USA)
-
Savannah Informatics: Innovating During the COVID-19 Pandemic
Schulman, Kevin; Kilonzi, Justus; Muthee, JohnCase SGSB-SM348-EStrategyIn February 2020, companies around the world contemplated their next moves as the pandemic news grew more grim each day. For Savannah Informatics, one of the first information services firms in Africa’s health care sector, the uncertainties and immediate supply chain challenges prompted nimble moves to make sure the technology continued to perform, but also served as a call to innovate further, and add new digital offerings. This case study addr...Starting at €8.20
-
Novartis’ Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries’ Health Care Systems - Teaching Note
Chess, R; Luthre, JTeaching Note SGSB-E489TN-EEntrepreneurshipInternational healthcare and reimbursement systems underwent a radical transformation in the 2000s, resulting from growing financial pressures incited by economic depression and a steady rise in healthcare spending. This phenomenon was most pronounced in the United States, where the health-spending share of GDP rose from five percent in 1960 to 17.9 percent in 2011. In Organization for Economic Co-operation and Development (OECD) countries on a...Starting at €0.00
-
Novartis’ Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries’ Health Care Systems
Chess, R; Luthre, JCase SGSB-E489-EEntrepreneurshipInternational healthcare and reimbursement systems underwent a radical transformation in the 2000s, resulting from growing financial pressures incited by economic depression and a steady rise in healthcare spending. This phenomenon was most pronounced in the United States, where the health-spending share of GDP rose from five percent in 1960 to 17.9 percent in 2011. In Organization for Economic Co-operation and Development (OECD) countries on a...Starting at €8.20